<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7231977</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">32435666</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7231977</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2352-2895(20)30007-2</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.ynstr.2020.100217</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">100217</article-id></all-ids><extracted-table><table-id>tbl1</table-id><table-label>Table 1</table-label><table-caption>Sample characteristics.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl1"><label>Table 1</label><caption><p>Sample characteristics.</p></caption><alt-text id="alttext0020">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Mean (SD) or %</th></tr></thead><tbody><tr><td align="left">Age, Years</td><td align="left">33.22 (11.55)</td></tr><tr><td align="left">Sex, Female %</td><td align="left">65%</td></tr><tr><td colspan="2" align="left">Race and Ethnicity %</td></tr><tr><td align="left"> African American/Black</td><td align="left">40.7%</td></tr><tr><td align="left"> Caucasian</td><td align="left">48.1%</td></tr><tr><td align="left"> Hispanic</td><td align="left">1.9%</td></tr><tr><td align="left"> Latino</td><td align="left">1.9%</td></tr><tr><td align="left"> Native American</td><td align="left">1.9%</td></tr><tr><td align="left"> Biracial</td><td align="left">3.7%</td></tr><tr><td align="left"> No information provided</td><td align="left">1.9%</td></tr><tr><td colspan="2" align="left">Education %</td></tr><tr><td align="left"> Graduated four-year college and beyond</td><td align="left">20.4%</td></tr><tr><td align="left"> Some post-secondary education/college</td><td align="left">42.6%</td></tr><tr><td align="left"> Completed high school</td><td align="left">27.8%</td></tr><tr><td align="left"> Did not complete high school</td><td align="left">7.4%</td></tr><tr><td align="left"> No education information provided</td><td align="left">1.9%</td></tr><tr><td colspan="2" align="left">Type of Trauma %</td></tr><tr><td align="left"> Motor vehicle crash</td><td align="left">75.9%</td></tr><tr><td align="left"> Physical Assault</td><td align="left">18.5%</td></tr><tr><td align="left"> Other type of non-vehicular incident</td><td align="left">5.6%</td></tr><tr><td align="left">Trauma Load (# of past trauma types experienced)</td><td align="left">7.66 (4.16)</td></tr><tr><td colspan="2" align="left">Self-Reported Lifetime Psychopathology</td></tr><tr><td align="left"> Depression and/or anxiety disorder</td><td align="left">13.0%</td></tr><tr><td align="left"> Eating Disorder (Anorexia Nervosa)</td><td align="left">1.9%</td></tr><tr><td align="left"> % at risk for alcohol use disorders (AUDIT-C)</td><td align="left">40.7%</td></tr><tr><td align="left"> % current substance use (only marijuana endorsed)</td><td align="left">5.6%</td></tr><tr><td colspan="2" align="left">Medication</td></tr><tr><td align="left"> % on Pain Medication</td><td align="left">29.6%</td></tr><tr><td align="left"> % on psychotropic medication</td><td align="left">18.5%</td></tr><tr><td colspan="2" align="left">Two-week assessment symptoms</td></tr><tr><td align="left"> Pain rating two-week post-trauma (0–10)</td><td align="left">3.13 (2.34)</td></tr><tr><td align="left"> Depressive symptoms two-week post-trauma (BDI-II)</td><td align="left">11.19 (8.08)</td></tr><tr><td align="left"> Anxiety symptoms two-week post-trauma (BAI)</td><td align="left">12.16 (10.30)</td></tr><tr><td align="left"> PTSD symptoms two-week post-trauma (IES-R)</td><td align="left">31.52 (18.49)</td></tr><tr><td colspan="2" align="left">Six-month assessment symptoms</td></tr><tr><td align="left"> PTSD symptoms six-month post-trauma (IES-R)</td><td align="left">19.01 (20.79)</td></tr><tr><td align="left"> % Clinically Significant PTSD symptoms (IES-R &gt;24)</td><td align="left">25.93%</td></tr><tr><td align="left"> Probable DSM-IV PTSD Diagnosis (IES-R &gt; 33)</td><td align="left">16.67%</td></tr></tbody></table><table-wrap-foot><fn><p>Note: AUDIT- C = Alcohol Use Disorders Identification Test- Consumption (a score ≥ 3 for females and a score of ≥4 for males is considered to be an indicator of problematic drinking) BDI-II = Beck Depression Inventory; BAI = Beck Anxiety Inventory; IES-R = Impact of Event Scale – Revised Psychotropic medications included use of SSRIs (9.3%), SNRI's (3.7%), Tricyclic antidepressants (1.9%), and benzodiazepines (9.3%).</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sample characteristics.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Mean (SD) or %</th></tr></thead><tbody><tr><td align="left">Age, Years</td><td align="left">33.22 (11.55)</td></tr><tr><td align="left">Sex, Female %</td><td align="left">65%</td></tr><tr><td colspan="2" align="left">Race and Ethnicity %</td></tr><tr><td align="left"> African American/Black</td><td align="left">40.7%</td></tr><tr><td align="left"> Caucasian</td><td align="left">48.1%</td></tr><tr><td align="left"> Hispanic</td><td align="left">1.9%</td></tr><tr><td align="left"> Latino</td><td align="left">1.9%</td></tr><tr><td align="left"> Native American</td><td align="left">1.9%</td></tr><tr><td align="left"> Biracial</td><td align="left">3.7%</td></tr><tr><td align="left"> No information provided</td><td align="left">1.9%</td></tr><tr><td colspan="2" align="left">Education %</td></tr><tr><td align="left"> Graduated four-year college and beyond</td><td align="left">20.4%</td></tr><tr><td align="left"> Some post-secondary education/college</td><td align="left">42.6%</td></tr><tr><td align="left"> Completed high school</td><td align="left">27.8%</td></tr><tr><td align="left"> Did not complete high school</td><td align="left">7.4%</td></tr><tr><td align="left"> No education information provided</td><td align="left">1.9%</td></tr><tr><td colspan="2" align="left">Type of Trauma %</td></tr><tr><td align="left"> Motor vehicle crash</td><td align="left">75.9%</td></tr><tr><td align="left"> Physical Assault</td><td align="left">18.5%</td></tr><tr><td align="left"> Other type of non-vehicular incident</td><td align="left">5.6%</td></tr><tr><td align="left">Trauma Load (# of past trauma types experienced)</td><td align="left">7.66 (4.16)</td></tr><tr><td colspan="2" align="left">Self-Reported Lifetime Psychopathology</td></tr><tr><td align="left"> Depression and/or anxiety disorder</td><td align="left">13.0%</td></tr><tr><td align="left"> Eating Disorder (Anorexia Nervosa)</td><td align="left">1.9%</td></tr><tr><td align="left"> % at risk for alcohol use disorders (AUDIT-C)</td><td align="left">40.7%</td></tr><tr><td align="left"> % current substance use (only marijuana endorsed)</td><td align="left">5.6%</td></tr><tr><td colspan="2" align="left">Medication</td></tr><tr><td align="left"> % on Pain Medication</td><td align="left">29.6%</td></tr><tr><td align="left"> % on psychotropic medication</td><td align="left">18.5%</td></tr><tr><td colspan="2" align="left">Two-week assessment symptoms</td></tr><tr><td align="left"> Pain rating two-week post-trauma (0–10)</td><td align="left">3.13 (2.34)</td></tr><tr><td align="left"> Depressive symptoms two-week post-trauma (BDI-II)</td><td align="left">11.19 (8.08)</td></tr><tr><td align="left"> Anxiety symptoms two-week post-trauma (BAI)</td><td align="left">12.16 (10.30)</td></tr><tr><td align="left"> PTSD symptoms two-week post-trauma (IES-R)</td><td align="left">31.52 (18.49)</td></tr><tr><td colspan="2" align="left">Six-month assessment symptoms</td></tr><tr><td align="left"> PTSD symptoms six-month post-trauma (IES-R)</td><td align="left">19.01 (20.79)</td></tr><tr><td align="left"> % Clinically Significant PTSD symptoms (IES-R &gt;24)</td><td align="left">25.93%</td></tr><tr><td align="left"> Probable DSM-IV PTSD Diagnosis (IES-R &gt; 33)</td><td align="left">16.67%</td></tr></tbody></table></div>Note: AUDIT- C = Alcohol Use Disorders Identification Test- Consumption (a score ≥ 3 for females and a score of ≥4 for males is considered to be an indicator of problematic drinking) BDI-II = Beck Depression Inventory; BAI = Beck Anxiety Inventory; IES-R = Impact of Event Scale – Revised Psychotropic medications included use of SSRIs (9.3%), SNRI's (3.7%), Tricyclic antidepressants (1.9%), and benzodiazepines (9.3%).</transformed-table></extracted-table><extracted-table><table-id>tbl2</table-id><table-label>Table 2</table-label><table-caption>Sensitivity analyses to test the robustness of RSFC-six-month post-trauma PTSD symptom associations when accounting for other relevant demographic, clinical, and trauma-related predictors.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl2"><label>Table 2</label><caption><p>Sensitivity analyses to test the robustness of RSFC-six-month post-trauma PTSD symptom associations when accounting for other relevant demographic, clinical, and trauma-related predictors.</p></caption><alt-text id="alttext0025">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Predictor</th><th><italic>B</italic></th><th><italic>β</italic></th><th><italic>t</italic></th><th><italic>p</italic></th></tr></thead><tbody><tr><td align="left">MR Scanner Type</td><td align="center">−0.660</td><td align="center">−0.139</td><td align="center">−1.319</td><td align="center">0.198</td></tr><tr><td align="left">Age</td><td align="center">0.001</td><td align="center">0.005</td><td align="center">0.052</td><td align="center">0.959</td></tr><tr><td align="left">Sex (male/female)</td><td align="center">−1.458</td><td align="center">−0.284</td><td align="center">−2.819</td><td align="center">0.009<xref rid="tbl2fna" ref-type="table-fn">a</xref></td></tr><tr><td align="left">Education (post-secondary/no post-secondary)</td><td align="center">−0.020</td><td align="center">−0.004</td><td align="center">−0.033</td><td align="center">0.974</td></tr><tr><td align="left">African American Race (versus Caucasian)</td><td align="center">0.618</td><td align="center">0.129</td><td align="center">1.108</td><td align="center">0.278</td></tr><tr><td align="left">Other Minority Race (versus Caucasian)</td><td align="center">−1.123</td><td align="center">−0.147</td><td align="center">−1.299</td><td align="center">0.205</td></tr><tr><td align="left">Physical Assault (versus motor vehicle crash)</td><td align="center">1.342</td><td align="center">0.225</td><td align="center">1.839</td><td align="center">0.077</td></tr><tr><td align="left">Other non-vehicular incident (versus motor vehicle crash)</td><td align="center">−0.612</td><td align="center">−0.064</td><td align="center">−0.476</td><td align="center">0.638</td></tr><tr><td align="left">Trauma Load</td><td align="center">−0.044</td><td align="center">−0.077</td><td align="center">−0.655</td><td align="center">0.518</td></tr><tr><td align="left">Psychotropic Medication</td><td align="center">0.053</td><td align="center">0.008</td><td align="center">0.070</td><td align="center">0.944</td></tr><tr><td align="left">Pain Medication</td><td align="center">0.203</td><td align="center">0.040</td><td align="center">0.403</td><td align="center">0.690</td></tr><tr><td align="left">Two-Week PTSD Symptoms (IES-R)</td><td align="center">0.013</td><td align="center">0.099</td><td align="center">0.598</td><td align="center">0.555</td></tr><tr><td align="left">Two-Week Depressive Symptoms (BDI-II)</td><td align="center">0.077</td><td align="center">0.256</td><td align="center">1.885</td><td align="center">0.070</td></tr><tr><td align="left">Two-Week Anxiety Symptoms (BAI)</td><td align="center">0.034</td><td align="center">0.145</td><td align="center">1.050</td><td align="center">0.303</td></tr><tr><td align="left">Two-Week Pain Rating</td><td align="center">0.042</td><td align="center">0.040</td><td align="center">0.382</td><td align="center">0.706</td></tr><tr><td align="left">Alcohol Use (AUDIT-C)</td><td align="center">0.026</td><td align="center">0.023</td><td align="center">0.223</td><td align="center">0.825</td></tr><tr><td align="left">Right Amygdala – Right Cerebellum RSFC (+14, −78, −52)</td><td align="center">−7.293</td><td align="center">−0.395</td><td align="center">−3.428</td><td align="center">0.002<xref rid="tbl2fna" ref-type="table-fn">a</xref></td></tr><tr><td align="left">Right Amygdala – Right Cerebellum RSFC (+12,-50, −26)</td><td align="center">−1.351</td><td align="center">−0.097</td><td align="center">−0.836</td><td align="center">0.411</td></tr><tr><td align="left">Left Amygdala – Left Postcentral/Precentral Gyrus RSFC</td><td align="center">−3.342</td><td align="center">−0.251</td><td align="center">−1.966</td><td align="center">0.060</td></tr></tbody></table><table-wrap-foot><fn id="tbl2fna"><label>a</label><p id="ntpara0015"><italic>p</italic> &lt;.05 More negative right amygdala -right cerebellum resting state functional connectivity (RSFC) survived as a predictor of six-month post-trauma PTSD symptom severity.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sensitivity analyses to test the robustness of RSFC-six-month post-trauma PTSD symptom associations when accounting for other relevant demographic, clinical, and trauma-related predictors.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Predictor</th><th>B</th><th>β</th><th>t</th><th>p</th></tr></thead><tbody><tr><td align="left">MR Scanner Type</td><td align="center">−0.660</td><td align="center">−0.139</td><td align="center">−1.319</td><td align="center">0.198</td></tr><tr><td align="left">Age</td><td align="center">0.001</td><td align="center">0.005</td><td align="center">0.052</td><td align="center">0.959</td></tr><tr><td align="left">Sex (male/female)</td><td align="center">−1.458</td><td align="center">−0.284</td><td align="center">−2.819</td><td align="center">0.009???</td></tr><tr><td align="left">Education (post-secondary/no post-secondary)</td><td align="center">−0.020</td><td align="center">−0.004</td><td align="center">−0.033</td><td align="center">0.974</td></tr><tr><td align="left">African American Race (versus Caucasian)</td><td align="center">0.618</td><td align="center">0.129</td><td align="center">1.108</td><td align="center">0.278</td></tr><tr><td align="left">Other Minority Race (versus Caucasian)</td><td align="center">−1.123</td><td align="center">−0.147</td><td align="center">−1.299</td><td align="center">0.205</td></tr><tr><td align="left">Physical Assault (versus motor vehicle crash)</td><td align="center">1.342</td><td align="center">0.225</td><td align="center">1.839</td><td align="center">0.077</td></tr><tr><td align="left">Other non-vehicular incident (versus motor vehicle crash)</td><td align="center">−0.612</td><td align="center">−0.064</td><td align="center">−0.476</td><td align="center">0.638</td></tr><tr><td align="left">Trauma Load</td><td align="center">−0.044</td><td align="center">−0.077</td><td align="center">−0.655</td><td align="center">0.518</td></tr><tr><td align="left">Psychotropic Medication</td><td align="center">0.053</td><td align="center">0.008</td><td align="center">0.070</td><td align="center">0.944</td></tr><tr><td align="left">Pain Medication</td><td align="center">0.203</td><td align="center">0.040</td><td align="center">0.403</td><td align="center">0.690</td></tr><tr><td align="left">Two-Week PTSD Symptoms (IES-R)</td><td align="center">0.013</td><td align="center">0.099</td><td align="center">0.598</td><td align="center">0.555</td></tr><tr><td align="left">Two-Week Depressive Symptoms (BDI-II)</td><td align="center">0.077</td><td align="center">0.256</td><td align="center">1.885</td><td align="center">0.070</td></tr><tr><td align="left">Two-Week Anxiety Symptoms (BAI)</td><td align="center">0.034</td><td align="center">0.145</td><td align="center">1.050</td><td align="center">0.303</td></tr><tr><td align="left">Two-Week Pain Rating</td><td align="center">0.042</td><td align="center">0.040</td><td align="center">0.382</td><td align="center">0.706</td></tr><tr><td align="left">Alcohol Use (AUDIT-C)</td><td align="center">0.026</td><td align="center">0.023</td><td align="center">0.223</td><td align="center">0.825</td></tr><tr><td align="left">Right Amygdala – Right Cerebellum RSFC (+14, −78, −52)</td><td align="center">−7.293</td><td align="center">−0.395</td><td align="center">−3.428</td><td align="center">0.002???</td></tr><tr><td align="left">Right Amygdala – Right Cerebellum RSFC (+12,-50, −26)</td><td align="center">−1.351</td><td align="center">−0.097</td><td align="center">−0.836</td><td align="center">0.411</td></tr><tr><td align="left">Left Amygdala – Left Postcentral/Precentral Gyrus RSFC</td><td align="center">−3.342</td><td align="center">−0.251</td><td align="center">−1.966</td><td align="center">0.060</td></tr></tbody></table></div>ap &lt;.05 More negative right amygdala -right cerebellum resting state functional connectivity (RSFC) survived as a predictor of six-month post-trauma PTSD symptom severity.</transformed-table></extracted-table><extracted-table><table-id>tbl3</table-id><table-label>Table 3</table-label><table-caption>Sensitivity analyses to test robustness of trauma imagery task FC - six month post-trauma PTSD symptom assocations when accounting for other relevant demographic, clinical, and trauma-related predictors.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl3"><label>Table 3</label><caption><p>Sensitivity analyses to test robustness of trauma imagery task FC - six month post-trauma PTSD symptom assocations when accounting for other relevant demographic, clinical, and trauma-related predictors.</p></caption><alt-text id="alttext0030">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Predictor</th><th><italic>B</italic></th><th><italic>β</italic></th><th><italic>t</italic></th><th><italic>p</italic></th></tr></thead><tbody><tr><td align="left">MR Scanner Type</td><td align="center">−0.173</td><td align="center">−0.038</td><td align="center">−0.256</td><td align="center">0.800</td></tr><tr><td align="left">Age</td><td align="center">0.012</td><td align="center">0.059</td><td align="center">0.510</td><td align="center">0.614</td></tr><tr><td align="left">Sex (male/female)</td><td align="center">−1.104</td><td align="center">−0.221</td><td align="center">−1.657</td><td align="center">0.109</td></tr><tr><td align="left">Education (post-secondary/no post-secondary)</td><td align="center">−0.280</td><td align="center">−0.056</td><td align="center">−0.387</td><td align="center">0.702</td></tr><tr><td align="left">African American Race (versus Caucasian)</td><td align="center">1.087</td><td align="center">0.231</td><td align="center">1.592</td><td align="center">0.123</td></tr><tr><td align="left">Other Minority Race</td><td align="center">0.008</td><td align="center">0.001</td><td align="center">0.008</td><td align="center">0.994</td></tr><tr><td align="left">Physical Assault (versus motor vehicle crash)</td><td align="center">0.929</td><td align="center">0.153</td><td align="center">0.998</td><td align="center">0.327</td></tr><tr><td align="left">Other non-vehicular incident (versus motor vehicle crash)</td><td align="center">−2.031</td><td align="center">−0.179</td><td align="center">−0.995</td><td align="center">0.328</td></tr><tr><td align="left">Trauma Load</td><td align="center">−0.097</td><td align="center">−0.170</td><td align="center">−1.138</td><td align="center">0.265</td></tr><tr><td align="left">Psychotropic Medication</td><td align="center">0.663</td><td align="center">0.109</td><td align="center">0.686</td><td align="center">0.498</td></tr><tr><td align="left">Pain Medication</td><td align="center">0.697</td><td align="center">0.136</td><td align="center">1.026</td><td align="center">0.314</td></tr><tr><td align="left">Two-Week PTSD Symptoms (IES-R)</td><td align="center">0.014</td><td align="center">0.112</td><td align="center">0.599</td><td align="center">0.554</td></tr><tr><td align="left">Two-Week Depressive Symptoms (BDI-II)</td><td align="center">−0.044</td><td align="center">−0.143</td><td align="center">−0.853</td><td align="center">0.401</td></tr><tr><td align="left">Two-Week Anxiety Symptoms (BAI)</td><td align="center">0.070</td><td align="center">0.304</td><td align="center">1.615</td><td align="center">0.118</td></tr><tr><td align="left">Two-Week Pain Rating</td><td align="center">0.062</td><td align="center">0.062</td><td align="center">0.410</td><td align="center">0.685</td></tr><tr><td align="left">Alcohol Use (AUDIT-C)</td><td align="center">0.155</td><td align="center">0.130</td><td align="center">1.001</td><td align="center">0.326</td></tr><tr><td align="left">Right Amygdala – Right Precentral/Postcentral Gyrus FC</td><td align="center">−4.720</td><td align="center">−0.337</td><td align="center">−2.207</td><td align="center">0.036*</td></tr><tr><td align="left">Left Amygdala – Left Midcingulate FC</td><td align="center">−4.487</td><td align="center">−0.322</td><td align="center">−1.909</td><td align="center">0.067</td></tr></tbody></table><table-wrap-foot><fn><p><bold>*</bold><italic>p</italic> &lt; .05 More negative right amygdala – right precentral/postcentral gyrus functional connectivity (FC) survived as a significant predictor of six-month post-trauma PTSD symptom severity.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sensitivity analyses to test robustness of trauma imagery task FC - six month post-trauma PTSD symptom assocations when accounting for other relevant demographic, clinical, and trauma-related predictors.</div>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Predictor</th><th>B</th><th>β</th><th>t</th><th>p</th></tr></thead><tbody><tr><td align="left">MR Scanner Type</td><td align="center">−0.173</td><td align="center">−0.038</td><td align="center">−0.256</td><td align="center">0.800</td></tr><tr><td align="left">Age</td><td align="center">0.012</td><td align="center">0.059</td><td align="center">0.510</td><td align="center">0.614</td></tr><tr><td align="left">Sex (male/female)</td><td align="center">−1.104</td><td align="center">−0.221</td><td align="center">−1.657</td><td align="center">0.109</td></tr><tr><td align="left">Education (post-secondary/no post-secondary)</td><td align="center">−0.280</td><td align="center">−0.056</td><td align="center">−0.387</td><td align="center">0.702</td></tr><tr><td align="left">African American Race (versus Caucasian)</td><td align="center">1.087</td><td align="center">0.231</td><td align="center">1.592</td><td align="center">0.123</td></tr><tr><td align="left">Other Minority Race</td><td align="center">0.008</td><td align="center">0.001</td><td align="center">0.008</td><td align="center">0.994</td></tr><tr><td align="left">Physical Assault (versus motor vehicle crash)</td><td align="center">0.929</td><td align="center">0.153</td><td align="center">0.998</td><td align="center">0.327</td></tr><tr><td align="left">Other non-vehicular incident (versus motor vehicle crash)</td><td align="center">−2.031</td><td align="center">−0.179</td><td align="center">−0.995</td><td align="center">0.328</td></tr><tr><td align="left">Trauma Load</td><td align="center">−0.097</td><td align="center">−0.170</td><td align="center">−1.138</td><td align="center">0.265</td></tr><tr><td align="left">Psychotropic Medication</td><td align="center">0.663</td><td align="center">0.109</td><td align="center">0.686</td><td align="center">0.498</td></tr><tr><td align="left">Pain Medication</td><td align="center">0.697</td><td align="center">0.136</td><td align="center">1.026</td><td align="center">0.314</td></tr><tr><td align="left">Two-Week PTSD Symptoms (IES-R)</td><td align="center">0.014</td><td align="center">0.112</td><td align="center">0.599</td><td align="center">0.554</td></tr><tr><td align="left">Two-Week Depressive Symptoms (BDI-II)</td><td align="center">−0.044</td><td align="center">−0.143</td><td align="center">−0.853</td><td align="center">0.401</td></tr><tr><td align="left">Two-Week Anxiety Symptoms (BAI)</td><td align="center">0.070</td><td align="center">0.304</td><td align="center">1.615</td><td align="center">0.118</td></tr><tr><td align="left">Two-Week Pain Rating</td><td align="center">0.062</td><td align="center">0.062</td><td align="center">0.410</td><td align="center">0.685</td></tr><tr><td align="left">Alcohol Use (AUDIT-C)</td><td align="center">0.155</td><td align="center">0.130</td><td align="center">1.001</td><td align="center">0.326</td></tr><tr><td align="left">Right Amygdala – Right Precentral/Postcentral Gyrus FC</td><td align="center">−4.720</td><td align="center">−0.337</td><td align="center">−2.207</td><td align="center">0.036*</td></tr><tr><td align="left">Left Amygdala – Left Midcingulate FC</td><td align="center">−4.487</td><td align="center">−0.322</td><td align="center">−1.909</td><td align="center">0.067</td></tr></tbody></table></div>*p &lt; .05 More negative right amygdala – right precentral/postcentral gyrus functional connectivity (FC) survived as a significant predictor of six-month post-trauma PTSD symptom severity.</transformed-table></extracted-table></extracted-tables-set>